Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction

Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction
复制标题

DOI:
10.1001/jamaoncol.2017.4881
复制
发表时间:
2018-04-01
期刊:
影响因子:
28.4
通讯作者:
Evans, Gareth R.
Evans, Gareth R.
中科院分区:
医学1区
文献类型:
--
作者:
van Veen, Elke M.;Brentnall, Adam R.;Evans, Gareth R.

文献摘要

被引文献

相似文献

重要性单核苷酸多态性(SNPs)已被证明与乳腺癌易感性相关,但如何将其纳入目前的乳腺癌风险预测模型的证据有限。目的确定一组18个SNPs(SNP 18)是否可用于预测乳腺癌,与经典的危险因素和乳腺摄影密度相结合。这项队列研究招募了9363名年龄在46岁至73岁之间的女性,这些女性以前没有乳腺癌诊断,这些女性来自PROCAS研究(筛查时预测癌症风险)的更大前瞻性队列,专门评估乳腺癌风险评估方法。从2009年10月至2015年6月,在英格兰大曼彻斯特的多个基于人群的筛查中心进行了入组。随访持续至2017年1月5日。暴露18个SNP的基因分型,视觉评估乳腺X线摄影密度百分比,主要结果和指标SNP 18对乳腺癌诊断的预测能力采用Logistic回归分析预测风险的四分位数范围的优势比评估浸润性和导管原位癌的风险。(平均[范围]年龄,59 [46-73]岁)。其中,466人被发现患有乳腺癌(271人患病; 195人发病)。SNP 18在未调整或调整乳腺摄影密度和经典因素时具有相似的预测性(每个四分位数范围的比值比分别为1.56; 95% CI,1.38-1.77和1.53; 95% CI,1.35-1.74),观察到的风险非常接近预期(调整后的预期比值比,0.98; 95% CI,0.69-1.28)。一项综合风险评估显示,18%的子队列的10年风险为5%或更高,而所有癌症的10年风险为30%,间隔检测癌症为35%,2+期癌症为42%。相比之下,33%的子队列低于2%的风险,但只占18%,17%,和15%的总,间隔,和阶段2+乳腺癌,分别。结论和相关性SNP 18增加了大量的信息,风险评估的基础上Tyrer-Cuzick模型和乳腺摄影密度。综合风险可能有助于风险分层筛查和预防策略。
IMPORTANCE Single-nucleotide polymorphisms (SNPs) have demonstrated an association with breast cancer susceptibility, but there is limited evidence on how to incorporate them into current breast cancer risk prediction models.OBJECTIVE To determine whether a panel of 18 SNPs (SNP18) may be used to predict breast cancer in combination with classic risk factors and mammographic density.DESIGN, SETTING, AND PARTICIPANTS This cohort study enrolled a subcohort of 9363 women, aged 46 to 73 years, without a previous breast cancer diagnosis from the larger prospective cohort of the PROCAS study (Predicting Risk of Cancer at Screening) specifically to evaluate breast cancer risk-assessment methods. Enrollment took place from October 2009 through June 2015 from multiple population-based screening centers in Greater Manchester, England. Follow-up continued through January 5, 2017.EXPOSURES Genotyping of 18 SNPs, visual-assessment percentage mammographic density, and classic risk assessed by the Tyrer-Cuzick risk model from a self-completed questionnaire at cohort entry.MAIN OUTCOMES AND MEASURES The predictive ability of SNP18 for breast cancer diagnosis (invasive and ductal carcinoma in situ) was assessed using logistic regression odds ratios per interquartile range of the predicted risk.RESULTS A total of 9363 women were enrolled in this study (mean [range] age, 59 [46-73] years). Of these, 466 were found to have breast cancer (271 prevalent; 195 incident). SNP18 was similarly predictive when unadjusted or adjusted for mammographic density and classic factors (odds ratios per interquartile range, respectively, 1.56; 95% CI, 1.38-1.77 and 1.53; 95% CI, 1.35-1.74), with observed risks being very close to expected (adjusted observed-to-expected odds ratio, 0.98; 95% CI, 0.69-1.28). A combined risk assessment indicated 18% of the subcohort to be at 5% or greater 10-year risk, compared with 30% of all cancers, 35% of interval-detected cancers, and 42% of stage 2+ cancers. In contrast, 33% of the subcohort were at less than 2% risk but accounted for only 18%, 17%, and 15% of the total, interval, and stage 2+ breast cancers, respectively.CONCLUSIONS AND RELEVANCE SNP18 added substantial information to risk assessment based on the Tyrer-Cuzick model and mammographic density. A combined risk is likely to aid risk-stratified screening and prevention strategies.